A phase II study of fulvestrant in premenopausal women with hormone receptor-positive breast cancer
Phase of Trial: Phase II
Latest Information Update: 20 Dec 2007
At a glance
- Drugs Fulvestrant (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 20 Dec 2007 Status changed from in progress to completed as reported on clinicaltrials.gov website.
- 07 Aug 2007 Status changed from recruiting to in progess.
- 08 Nov 2005 New trial record.